Pharmaceutical cold chain logistics in Europe has become mission-critical, not just for vaccines and biologics, but for a broader shift toward personalized and temperature-sensitive therapies. The market is expected to grow from USD 16.9 billion in 2023 to USD 24.6 billion by 2030, at a CAGR of 5.5%. Tightening EU GDP (Good Distribution Practice) regulations and increasing reliance on cell, gene, and mRNA-based therapies are driving this evolution. Over 70% of pharma products now require some degree of cold chain handling, particularly within the 2°C to 8°C range.

‍

The shift toward real-time monitoring and sensor-based visibility is also reshaping cold chain management. Experts report that temperature excursion-related losses have dropped by 30–35% in organizations that adopted digital cold chain tech. Air freight dominates long-haul supply chains, while GDP-compliant road freight is rapidly scaling across Western and Central Europe. Outsourcing is on the rise too—over 60% of pharma cold chain operations in Western Europe are now managed by third-party logistics (3PL) providers, enabling scale and compliance at lower costs.

‍

    Key Quantitative Takeaways

‍

• Market value: USD 24.6B by 2030, growing at 5.5% CAGR
  
  
• Biologics, CGT, and specialty drugs make up ~70%+ of cold chain volume
  
  
• 2°C to 8°C segment dominates temperature control formats
  
  
• Digital monitoring cuts spoilage losses by up to 35%
  
  
• 3PL outsourcing penetration at 60%+ in Western Europe
  
  

Download the full transcript for country-level investment trends, tech integration benchmarks, and expert views on the future of pharma logistics in Europe.

‍

• Temperature-controlled logistics market
  
  
• EU GDP pharma logistics
  
  
• Biologics cold chain transportation
  
  
• Cell and gene therapy logistics
  
  
• Cold chain market size Europe
  
  
• mRNA vaccine supply chain Europe
  
  
• Pharma logistics digital tracking
  
  
• GDP-compliant logistics providers
  
  
• Cold chain outsourcing in Europe
  
  
• Real-time temperature monitoring pharma
  
  
• Specialty drug distribution Europe
  ‍

‍

• Request a Customized Transcript: Submit your own questions or specify changes. We’ll conduct a new call with the industry expert, covering both the original and your additional questions. You’ll receive an updated report for a small fee over the standard price.
• Request a Direct Call with the Expert: If you prefer a live conversation, we can facilitate a call between you and the expert. After the call, you’ll get the full recording, a verbatim transcript, and continued platform access to query the content and more.

‍